Saki Shimizu
Mitaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors.
Journal: Brain tumor pathology
Published: August 21, 2020
Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.
Journal: Japanese journal of clinical oncology
Published: April 19, 2020
Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy.
Journal: Japanese journal of clinical oncology
Published: February 03, 2020
Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.
Journal: Japanese journal of clinical oncology
Published: March 03, 2017
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.
Journal: Acta neuropathologica communications
Published: July 19, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Journal: Acta neuropathologica
Published: October 17, 2015
Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
Journal: International journal of clinical oncology
Published: September 24, 2012
Isolation and antioxidant activity of zeylaniin A, a new macrocyclic ellagitannin from Syzygium zeylanicum leaves.
Journal: Journal of agricultural and food chemistry
Published: September 15, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026